TY - JOUR
T1 - Patient, Parental, and Health Professional Perspectives on Growth in Children With CKD
AU - Wu, Justin G.
AU - Guha, Chandana
AU - Hughes, Anastasia
AU - Torrisi, Luca G.
AU - Craig, Jonathan C.
AU - Sinha, Aditi
AU - Dart, Allison
AU - Eddy, Allison A.
AU - Bockenhauer, Detlef
AU - Yap, Hui Kim
AU - Groothoff, Jaap
AU - Alexander, Stephen I.
AU - Furth, Susan L.
AU - Samuel, Susan
AU - Carter, Simon A.
AU - Walker, Amanda
AU - Kausman, Joshua
AU - Jaure, Allison
PY - 2025/1
Y1 - 2025/1
N2 - Rationale & Objective: Growth failure is a common problem among children with chronic kidney disease (CKD). Reduced height is associated with psychosocial burden, social stigma, and impaired quality of life. This study describes the aspects of growth impairment that are most impactful from the perspectives of children with CKD, their parents, and health professionals. Study Design: Qualitative study. Settings & Participants: 120 children with CKD (aged 8-21 years), 250 parents, and 445 health professionals from 53 countries who participated in 16 focus groups, 2 consensus workshops, and a Delphi survey. Analytical Approach: A thematic analysis of all qualitative data concerning growth from the Standardized Outcomes in Nephrology–Children and Adolescents (SONG-Kids) initiative. Results: We identified 5 themes: diminishing psychological well-being (compared to and judged by peers, tired of explaining to others, damaging self-esteem), constrained life participation and enjoyment (deprived of normal school experiences, excluded from sports or competing at a disadvantage, impaired quality of life in adulthood); grappling with impacts of symptoms and treatment (difficulty understanding short stature and accessing help, lack of appetite, uncertainty regarding bone pains, medication side effects, burden of growth hormone treatment); facilitating timely interventions and optimizing outcomes (early indicator of disease, assessing management, maximizing transplant outcomes, minimizing morbidity); and keeping growth and health priorities in perspective (quality of life and survival of utmost priority, achieved adequate height). Limitations: Only English-speaking participants were included. Conclusions: Impaired growth may diminish psychological well-being, self-esteem, and participation in daily activities for children with CKD. Balancing different treatments that can affect growth complicates decision making. These findings may inform the psychosocial support needed by children with CKD and their caregivers to address concerns about growth. Plain-Language Summary: Children with chronic kidney disease (CKD) are often much shorter than their peers and may experience poorer mental health and quality of life. To understand the specific important issues on how growth impairment affects these children, we collected qualitative data from the Standardized Outcomes in Nephrology–Children and Adolescents (SONG-Kids) initiative and analyzed perspectives on growth from patients, parents, and health professionals. These data revealed impaired psychological health, reduced enjoyment during school and sports, difficulty dealing with medication side effects and growth hormone treatment, and concerns related to tracking health status and kidney transplant outcomes. These findings may inform the psychosocial support needed by children with CKD and their caregivers to address concerns about growth and overall health.
AB - Rationale & Objective: Growth failure is a common problem among children with chronic kidney disease (CKD). Reduced height is associated with psychosocial burden, social stigma, and impaired quality of life. This study describes the aspects of growth impairment that are most impactful from the perspectives of children with CKD, their parents, and health professionals. Study Design: Qualitative study. Settings & Participants: 120 children with CKD (aged 8-21 years), 250 parents, and 445 health professionals from 53 countries who participated in 16 focus groups, 2 consensus workshops, and a Delphi survey. Analytical Approach: A thematic analysis of all qualitative data concerning growth from the Standardized Outcomes in Nephrology–Children and Adolescents (SONG-Kids) initiative. Results: We identified 5 themes: diminishing psychological well-being (compared to and judged by peers, tired of explaining to others, damaging self-esteem), constrained life participation and enjoyment (deprived of normal school experiences, excluded from sports or competing at a disadvantage, impaired quality of life in adulthood); grappling with impacts of symptoms and treatment (difficulty understanding short stature and accessing help, lack of appetite, uncertainty regarding bone pains, medication side effects, burden of growth hormone treatment); facilitating timely interventions and optimizing outcomes (early indicator of disease, assessing management, maximizing transplant outcomes, minimizing morbidity); and keeping growth and health priorities in perspective (quality of life and survival of utmost priority, achieved adequate height). Limitations: Only English-speaking participants were included. Conclusions: Impaired growth may diminish psychological well-being, self-esteem, and participation in daily activities for children with CKD. Balancing different treatments that can affect growth complicates decision making. These findings may inform the psychosocial support needed by children with CKD and their caregivers to address concerns about growth. Plain-Language Summary: Children with chronic kidney disease (CKD) are often much shorter than their peers and may experience poorer mental health and quality of life. To understand the specific important issues on how growth impairment affects these children, we collected qualitative data from the Standardized Outcomes in Nephrology–Children and Adolescents (SONG-Kids) initiative and analyzed perspectives on growth from patients, parents, and health professionals. These data revealed impaired psychological health, reduced enjoyment during school and sports, difficulty dealing with medication side effects and growth hormone treatment, and concerns related to tracking health status and kidney transplant outcomes. These findings may inform the psychosocial support needed by children with CKD and their caregivers to address concerns about growth and overall health.
KW - Children
KW - chronic kidney disease
KW - dialysis
KW - growth
KW - patient-centered care
KW - renal failure
KW - transplant
UR - http://www.scopus.com/inward/record.url?scp=85206151923&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/1092957
U2 - 10.1053/j.ajkd.2024.06.016
DO - 10.1053/j.ajkd.2024.06.016
M3 - Article
C2 - 39127401
AN - SCOPUS:85206151923
SN - 0272-6386
VL - 85
SP - 14-24.e1
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 1
ER -